

News & Views
Parkinson’s disease is the fastest growing neurological condition in the world. Between 1990 and 2015, the number of people with this disease doubled to over 6 million [1]. This number is predicted to double again to 12 million by 2040, primarily because of an ageing population [1]. In the UK, the lifetime risk of …
Porterhouse Medical Group is delighted to welcome Josh Ray to our global research, insights and evidence consultancy, Porterhouse Insights. Josh is joining the team as a Research Executive, having graduated from Imperial College London in 2021 with an MSci in Chemistry, where he focussed on the molecular imaging of G-quadruplex DNA for his final year …
Continue reading “Porterhouse Insights welcomes a new starter to their growing team”
The Porterhouse Medical team were proud to attend this year’s ISMPP EU meeting on driving leadership and best practice in Medical Communications. Two of our medical writers also presented their posters on preprints and digital enhancements, based on research conducted jointly between Porterhouse Medical Group and our colleagues at integrated medhealth communication (imc), UK. Take …
In light of the horrifying situation in Ukraine and in support of one of our charity partners for this year, the Reading Refugee Support Group, the Porterhouse Charity Team have collated a few ways in which we can help the refugees affected by this crisis. Reading Refugee Support Group The Reading Refugee Support Group …
Continue reading “Working with our charity partners: How we can help the Ukrainian refugees”
Porterhouse Medical Group is thrilled to announce the promotions of two valued members of our global scientific services team. First, we would like to congratulate Hannah Tomlin on her promotion to Medical Writer. Hannah joined our Nottingham office in September 2021 and has quickly become a key member of the team, impressing colleagues and clients …
Continue reading “Celebrating a double promotion in Porterhouse’s global scientific services team”
With the easing of pandemic travel restrictions, Porterhouse teams are weighing up the pros and cons of engaging with clients via virtual meetings versus spending quality time in real-life, face-to-face meetings. Our Environmental and Sustainability Committee calculated that over half of our carbon footprint as a company has traditionally come from air travel to global …
Continue reading “Porterhouse Medical gets on the right track to reducing its carbon footprint”
World Tuberculosis (TB) Day is observed each year on 24 March to raise public awareness of the devastating impact of this disease on the lives of patients [1]. This date marks the announcement in 1882 of the discovery of the bacterium that causes TB, Mycobacterium tuberculosis, which paved the way for effective methods for …
Continue reading “World Tuberculosis Day: ‘Invest to End TB. Save Lives’”
Porterhouse Medical Group is delighted to announce a third promotion this month and congratulate Holly Hardstone on her promotion to the role of Medical Writer. Holly joined our global scientific services team in September 2021, with an MSc in pharmacy from the University of Bath and two years’ valuable experience working as a pharmacist. Since then, …
Porterhouse Medical Group is delighted to announce that Alice Wright has been promoted to the role of Account Director. Alice is a long-standing member of the Porterhouse family, having joined our global client services team in May 2017. Since then, she has been instrumental in driving the growth of a key global pharmaceutical account and the …
With more of the Porterhouse family returning to work in the office, we are delighted to announce that the Porterhouse Social Exercise Group is back. This group is one of our fun initiatives to support the mental and physical health of our busy teams, providing a friendly space for people of all abilities to …
Continue reading “The Porterhouse Social Exercise Group is back up and ‘running’ again”
Porterhouse Medical Group is delighted to announce the promotion of Emma Handley to Principal Medical Writer. Emma is a long-standing member of our global scientific services team, having joined Porterhouse in 2006 with a BSc in biochemistry from the University of Nottingham. She began her career at Porterhouse as a medical writer; since then, …
Background Epilepsy is a chronic neurological condition that affects approximately 50 million people worldwide. It is characterised by recurrent seizures due to excessive electrical discharges in the brain [1]. Seizures experienced by individuals with epilepsy can be categorised as generalised (affecting both sides of the brain) or focal (located in one specific area of the …
Continue reading “Epilepsy Awareness: A spotlight on Dravet Syndrome”